⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Vilazodone

ویلازودون

⚠ Unverified

🧠 Nervous SystemAntidepressant (SSRI + 5-HT1A partial agonist)

🤰 Pregnancy:Use with caution 👶 Children:Dangerous / avoid 👴 Older adults:Use with caution 🇮🇷 Registered in Iran ⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA022567 ATC N06AX24

Market / country: 🇺🇸 USA

Viibryd (US)

🧮 Dose calculator

Disease / regimen

Major depressive disorder · Regimen source: FDA Viibryd · 2.1

• Start 10 mg for 7 days, then 20 mg; after ≥7 days up to 40 mg. Screen for bipolar disorder first. Taper when stopping. FDA Viibryd · 2.1 FDA Viibryd · 2.2

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ MAOIs concomitantly, within 14 days of stopping them, or within 14 days of stopping this drug; linezolid or IV methylene blue (serotonin syndrome). FDA Viibryd · 4

Warnings

• Boxed warning: increased suicidal thoughts and behaviours in children and young adults — monitor for clinical worsening. FDA Viibryd · Boxed Warning
• Serotonin syndrome; seizures; sexual dysfunction. FDA Viibryd · 5

Formulations

20 mg tablet — tablet 🇺🇸 USA FDA Viibryd · 3
40 mg tablet — tablet 🇺🇸 USA FDA Viibryd · 3
10 mg tablet — tablet 🇺🇸 USA FDA Viibryd · 3

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Viibryd · 8.1
“Risk Summary Based on data from published observational studies, exposure to SSRIs, particularly in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage [see Warnings and Precautions ( 5.3 ) and Clinical Considerations] .”
🤱 BreastfeedingNo data
The source for this drug has no section for this group.
👶 ChildrenDangerous / avoid
Boxed warning in the label about children. FDA Viibryd · Boxed Warning
“Antidepressants increased the risk of suicidal thoughts and behavi ors in pediatric and young adult patients in short-term studies.”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Viibryd · 8.5
“Serotonergic antidepressants have been associated with cases of clinically significant hyponatremia in elderly patients, who may be at greater risk for this adverse reaction [see Warnings and Precautions ( 5.8 )] .”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)NDA022567
DailyMed (FDA label)FDA Viibryd
MedlinePlus (NIH)Vilazodone
WHO ATC/DDDN06AX24
Darooyab (Iran)VILAZODONE

🇮🇷 Registered in Iran Darooyab · G-4709/VILAZODONE

Dosage forms with Iranian generic codes, per Darooyab.

19933 · VILAZODONE 20MG TAB · قرص ویلازودون ۲۰ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Viibryd · 3 FDA Viibryd · 2.1 FDA Viibryd · 2.2 FDA Viibryd · 4 FDA Viibryd · Boxed Warning FDA Viibryd · 5 FDA Viibryd · SPL approval / marketing category FDA Viibryd · 8.1 FDA Viibryd · 8.5
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-4709/VILAZODONE
Clinical review⚠ Unverified